Ovala, Inc.

SEC filing

Biotechnology · Pittsburgh, PA

Form D on EDGAR

Amount raised$3.3Msold at filing

Total offering$13M$9.7M still open

Investors in the raise8count reported to the SEC

FiledMar 31, 2026first sale Mar 16, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Christopher PetersenDirector

John SippleExecutive Officer

Richard PetersenDirector

Brad PetersenDirector

Stephen BollingerExecutive Officer, Director

Michael TovianDirector

Jeffrey QuillenDirector

Executive officers, directors and promoters as listed on the Form D.